ArticleScientific reports2019

Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma.

Frank Eckerdt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.